top of page

INSIGHTS
Search
FRAND-ING PATENT LICENSES AND ITS IMPLICATION IN LANDMARK CASES IN INDIA
Everyday, a number of products are being invented all over the world, some cascading over the improvement of existing inventions, and the...
Feb 27, 201711 min read
Expedited examination and non-expedited (normal) examination: Who can file request for examination?
With effect from May 16, 2016 (effective date for Patent (amendment) rules, 2016) , provision of expedited examination was introduced in...
Feb 27, 20172 min read
Teva held responsible for Induced Infringement of Eli Lilly’s Blockbuster drug ALITMA
In Teva Parenteral Medicines, Inc.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O.; Teva Pharmaceuticals USA, Inc.; and Barr...
Feb 24, 20176 min read
India: Do we need Patent Term Extension and Non-Patent Exclusivities for Pharmaceuticals?
India, though in a phase of rapid economic development, still has the bane of poverty. In this country, around 22% of the population is...
Jan 11, 20176 min read
Analysis of the rejection of Lumacaftor (Polymorph) patent application in India
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to rejection...
Jan 11, 20173 min read
A Primer to Patent Application Drafting with special emphasis on standard practise(s) before the Indian Patent Office
An enforceable Patent being the key to effective Commercialization/Out-Licensing of any technology needs to be drafted well. No matter...
Jan 2, 20172 min read
PATENT INFRINGMENT SUIT BY DOLBY AGAINST OPPO AND VIVO
Anjana Mohan, an intern at Khurana & Khurana, Advocates and IP Attorneys deals with the updates in the Patent Litigation between Dolby...
Dec 27, 20162 min read
Merk’s patent valid but Teva’s Nasonex generic non-infringing
In Merck Sharp & Dohme Corp. (hereinafter referred to be as “Merck”) v. Teva Pharms. United States, Inc. (hereinafter referred to be as...
Dec 27, 20163 min read
Hetero’s Subsidiaries not infringing Roxane’s patent on PhosLo
In Roxane Laboratories, Inc. (hereinafter referred to be as “Roxane”) v. Camber Pharmaceuticals Inc., et al. (hereinafter referred to as...
Dec 14, 20163 min read
Inside Secure states, France Brevets licenses NFC Patents to HTC
Access to robust data and effective analytics are the must for today's business world. But sometimes it can be difficult to acquire good...
Nov 26, 20162 min read
RENOVA Expands Intellectual Property Portfolio For Cardiovascular And Metabolic Disease Treatments
Renova Therapeutics(hereinafter referred as “Renova”) founded in 2009 and headquartered in San Diego, California, a biopharmaceutical...
Nov 18, 20162 min read
Interplay of section 63 and section 64 of Indian Patent Act, 1970
What is the effect of surrender proceedings on the ongoing opposition/ revocation proceedings? Can they be linked to each other when...
Nov 8, 20164 min read
GOD BLESS NOVEMBER 27, 2016
Well, I am sure, this is what is crossing through the minds of the IP enthusiasts who have been waiting since long (2013-being specific)...
Oct 18, 20161 min read
HOW TO CALCULATE TERM OF/ EXPIRY OF INDIAN PATENT?
In order to analyse Patent infringement or to conclude Freedom to Operate (FTO) search, one must know how to calculate expiry of...
Oct 17, 20166 min read
Medicines Patent Pool’s Voluntary Licensing; Unique in its efforts to better treat the Infection
Efforts of Medicines Patent Pool (hereinafter referred to as “MPP”); a United Nations backed public health organisation, founded in July...
Sep 28, 20162 min read


Does Focusing on Single Embodiment Limits the Patent Specification?
This issue was handled by the United States Court of Appeals for the Federal Circuit in the SCRIPTPRO LLC, SCRIPTPRO USA, INC.,...
Aug 31, 20163 min read
Can Inventors Who Contribute to Only One Claim or One Aspect of One Claim of a Patent, may be Listed on Patent?
This question was handled by United States Court of Appeals for the Federal Circuit in the case of VAPOR POINT LLC, KEITH NATHAN, KENNETH...
Aug 31, 20163 min read
Patent Cooperation Treaty National Phase Entry in India: 31 months Period: Effect of Patent (Amendment) Rules, 2016
Under Patent Cooperation Treaty (PCT), applicant gets varying period of 30-34 months to enter different states with National Phase...
Jul 11, 20164 min read
Choosing India as International Search Authority (ISA) and International Preliminary Examining Authority (IPEA): Who Can and Who Cannot
It is long since October 15 th , 2013, that India started to work as International Search Authority (ISA) and International Preliminary...
Jul 11, 20162 min read
Federal Circuit Rules 180-Day Post-Licensure Notice is Mandatory in Biosimilar Litigation
In Amgen v. Apotex (No. 2016-1308), the US Court of Appeals for the Federal Circuit on July 5, 2016 affirmed a district court’s ruling...
Jul 11, 20165 min read
bottom of page


